HIFU for Treatment of Non-nodular and Recurrent BCC

Inclusion Criteria

• •Subjects of each gender aged 18 years or older at the time of informed consent. There is no upper limit of age.
• •Subjects who have received oral and written study information, accepted participation and signed the informed consent document.
• •Subjects who are willing and mentally and physically capable to understand and follow the treatment and follow-up schedule including post-treatment care instructions.
• •Subjects who are willing to have photographs and images taken of the treated lesions to be used anonymously or coded in evaluations and publications.
• •Subjects, who have histologically and clinically verified basal cell carcinoma either as newly diagnosed non-nodular cancer (one group) or as a recurrent cancer in a local site (another group) previously treated with any method practiced in dermatology clinics, hospital or the primary sector. Tumors of thickness more than 2.0 mm measured by ultrasound or OTC are considered of the "nodular" type. Thus, only tumors of thickness 2.0mm and less are included.